Co-Diagnostics Inc — Quarterly Cash Flow (NASDAQ:CODX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Total assets 72.38 M64 M55.15 M46.47 M44.74 M Total liabilities 8.6 M9.69 M7.23 M5.33 M4.91 M Total equity 63.78 M54.31 M47.92 M41.14 M39.83 M Total liabilities & shareholders' equities 72.38 M64 M55.15 M46.47 M44.74 M Total debt ————— Net debt —————

Nouvelles

Will Community Health's $450M Hospital Divestment Reduce Debt Burden?

Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25 - TipRanks.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.80%

Co-Diagnostics sera retiré du Nasdaq, les échanges déplacés vers le marché OTC

Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market

CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform

L’action de Co-Diagnostics chute après l’annonce d’un regroupement d’actions de 1 pour 30

Co-Diagnostics stock plunges after announcing 1-for-30 reverse split

Co-Diagnostics annonce un regroupement d’actions à raison de 1 pour 30

Co-Diagnostics announces 1-for-30 reverse stock split

Co-diagnostics reçoit un brevet australien pour sa plateforme de tests PCR

Co-diagnostics receives Australian patent for PCR testing platform